Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... graft-versus-host disease (GVHD) in patients with acute lymphocytic leukemia, acute myeloid leukemia, or chronic myelogenous leukemia undergoing donor peripheral blood stem cell transplant ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  2. Clinical Trials Report for December 2015

    ... transplantation will be given to patients with high risk acute myelogenous leukemia (AML) or myelodysplastic syndrome (MDS). This ...

    Page last updated 11/30/2015 - 10:31am.

  3. Chronic Myeloproliferative Neoplasms (MPN)

    ... of cell which is most affected. They include: Chronic myelogenous leukemia (CML), the overproduction of white cells (granulocytes) ... neoplasms and myelodysplastic syndromes may become acute leukemia, another type of blood cancer. ...

    Topic section last updated 07/07/2016 - 3:19pm.

  4. MDS - Treatment (OLD)

    ... The risk of developing Acute Myelogenous Leukemia (AML) depends on the type of MDS you have. As a ...

    Topic section last updated 03/10/2016 - 11:01pm.

  5. Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD in Children

    ... and have one of the following diagnoses: Acute lymphocytic leukemia in first or subsequent remission Acute myeloid ... with excess blasts (RAEB-1 and RAEB-2) Chronic myelogenous leukemia with a history of accelerated phase or blast crisis ...

    Clinical Trial last updated 06/13/2016 - 2:29pm.

  6. Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

    ... cord blood progenitor cells works in treating patients with acute myeloid leukemia, acute lymphoblastic leukemia, chronic myelogenous leukemia, or myelodysplastic syndromes. Giving chemotherapy ...

    Clinical Trial last updated 04/27/2016 - 1:17pm.

  7. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... Leukemias/lymphomas Acute myeloid leukemia, primary or secondary Disease status: remission or <10% ... Disease status: in hematologic remission Chronic myelogenous leukemia Disease status: chronic phase, accelerated phase or blast ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  8. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... Leukemias/lymphomas Acute myeloid leukemia, primary or secondary Disease status: remission or <10% ... Disease status: in hematologic remission Chronic myelogenous leukemia Disease status: chronic phase, accelerated phase or blast ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  9. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    ... Purpose:  Acute Graft-versus-Host-Disease (GVHD) is an important cause of morbidity and ... 76.0 years old) Patients with acute leukemia, chronic myelogenous leukemia or myelodysplasia with no circulating blasts and ...

    Clinical Trial last updated 06/06/2016 - 1:59pm.

  10. Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant

    ... must have one of the following disease types: Acute myeloid leukemia (AML) with disease features as described in the ... disease features as described in the protocol. Chronic myelogenous leukemia (CML) with disease features as described in the protocol. ...

    Clinical Trial last updated 06/06/2016 - 3:37pm.